Expertise in
12
conditions

Sophie Girod-Dupuis

Hospices Civils De Lyon
Bron, FR 
Expertise in
12
conditions
Hospices Civils De Lyon
Bron, FR 

Overview

Sophie Girod-Dupuis practices practicing medicine in Bron, France.

Ms. Girod-Dupuis is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Hereditary Hemorrhagic Telangiectasia, Telangiectasia, Pulmonary Arteriovenous Malformation (PAVM), Arteriovenous Malformation, and Liver Transplant.

She is actively involved in clinical research, co-authoring 102 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Hospices Civils de Lyon
Bron, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - Randomized Trial Versus Placebo
Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - Randomized Trial Versus Placebo
Enrollment Status: Completed
Publish Date: August 08, 2025
Intervention Type: Drug
Study Phase: Phase 2
BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hereditary Telangiectasia (HHT). A National, Multicenter Phase III Study
BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hereditary Telangiectasia (HHT). A National, Multicenter Phase III Study
Enrollment Status: Completed
Publish Date: August 06, 2025
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

102 Total Publications

Functional and Molecular Characterization of Novel GDF2 (BMP9) and BMP10 Variants From the French PAH and HHT Cohorts.
Functional and Molecular Characterization of Novel GDF2 (BMP9) and BMP10 Variants From the French PAH and HHT Cohorts.
Journal: Circulation. Genomic and precision medicine
Published: June 09, 2026

Frequently Asked Questions about Sophie Girod-Dupuis

Is Sophie Girod-Dupuis a top-rated expert for Hereditary Hemorrhagic Telangiectasia?

MediFind is an objective health platform that identifies experts based on real-world data. Sophie Girod-Dupuis is classified as an Elite expert for Hereditary Hemorrhagic Telangiectasia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sophie Girod-Dupuis participate in research or clinical trials?

Yes. Sophie Girod-Dupuis has published 102 articles and abstracts on conditions like Hereditary Hemorrhagic Telangiectasia. You can view a list of Sophie Girod-Dupuis's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Girod-Dupuis's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 21 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile